Vimarsana
Biggest News Aggregation in the World

Page 12 - Greg Laub News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Laub. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Laub Today - Breaking & Trending Today

PROs Support Practice-Changing RUBY Trial in Endometrial Cancer - Vimarsana News

PROs Support Practice-Changing RUBY Trial in Endometrial Cancer

Adding dostarlimab upfront does not add significant toxicity for patients, says Pamela Soliman

What Does the Evidence Say About Immunotherapy Rechallenge in RCC? - Vimarsana News

What Does the Evidence Say About Immunotherapy Rechallenge in RCC?

Kathryn Beckermann, MD, shares insights on the evolving treatment landscape in metastatic RCC

Including Polatuzumab Vedotin in First-Line DLBCL Treatment - Vimarsana News

Including Polatuzumab Vedotin in First-Line DLBCL Treatment

Ian Flinn, MD, PhD, leads a discussion on the future successors to the current standard of care

Closing the Diversity Gaps in Urologic Oncology Leadership - Vimarsana News

Closing the Diversity Gaps in Urologic Oncology Leadership

Simone Thavaseelan points out that it takes hard work to make leadership in urology more diverse

Reaction to FDA's Approval of Upadacitinib for Crohn's Disease - Vimarsana News

Reaction to FDA's Approval of Upadacitinib for Crohn's Disease

Our expert roundtable dives into the JAK inhibitor's new indication